FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Accepts Alvotech AVT03 BLA

FDA accepts a BLA submitted by Dr. Reddys and Alvotech for a biosimilar form of Amgens Prolia and Xgeva.

latest-news-card-1
Human Drugs

CGMP Violations at Canadas Vegewax Candleworx

FDA warns Concord, Ontario, Canada-based Vegewax Candleworx about CGMP violations in its production of finished drugs.

latest-news-card-1
Medical Devices

Smiths Medical Recalls Venous Access System

Smiths Medical recalls its ProPort Plastic Venous Access System because the devices plastic port housing and port reservoir may separate.

latest-news-card-1
Human Drugs

2 ICH Guidelines Advance

The International Council for Harmonization says the M11 and M13B guidelines have advanced to the second public consultation.

latest-news-card-1
Federal Register

Device Consensus Standards Publication

Federal Register notice: FDA updates its publication on modifications to the list of recognized consensus standards for use in device premarket review...

latest-news-card-1
Human Drugs

Keytruda Full Approval for Gastroesophageal Cancer

FDA awards Merck traditional approval for Keytruda (pembrolizumab) for use in combination with trastuzumab and chemotherapy for the first-line treatme...

Medical Devices

bioMrieux Gets Vitek Compact Pro Cleared

FDA clears a bioMrieux 510(k) for the latest version of its Vitek Compact Pro for microorganism identification and antibiotic susceptibility testing.

latest-news-card-1
Human Drugs

Sarepta Reports Death Linked to Elevidys

Sarepta says a young man with Duchenne muscular dystrophy being treated with Elevidys has died from acute liver failure.

latest-news-card-1
Human Drugs

Balance Drug Approval Flexibility, Evidence: Study

Harvard University researchers say drug regulators must balance incentives for expedited approvals of first-in-class drugs with evidence supporting ef...

latest-news-card-1
Human Drugs

Nurix Gets Orphan Status for Bexobrutideg

FDA grants Nurix Therapeutics an orphan drug designation for bexobrutideg and its use in treating Waldenstrm macroglobulinemia.